Literature DB >> 24261602

Is there a relation between clinical disease activity and acute phase response in Behcet's disease?

Mehmet Melikoglu1, Zeynep Topkarci.   

Abstract

The aim of this study was to evaluate a possible relation between clinical disease activity determined by a scale validated and most widely used acute phase response parameters in patients with Behcet's Disease (BD). One hundred patients with BD were included in this study. The demographic properties including age, sex, and disease durations were recorded. BD Current Activity Form (BDCAF), which scores the history of clinical features that have been present during the four weeks prior to the day of assessment, was used for the evaluation of disease activity. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were evaluated as acute phase response. The independent samples t test and Pearson's correlation test were performed for the statistical analysis. There were 60 male and 40 female patients with an age range of 19-51 years. The disease durations of the patients were between 12 and 240 months. In the comparison of the laboratory parameters of the patients with or without the components of BDCAF, we found significantly higher levels of ESR and CRP in patients with erythema and arthralgia-arthritis versus without these involvements. There were significant positive correlations between ESR-CRP levels and patient's perception of disease activity (P = 0.012 and P < 0.05, respectively), clinician's overall perception of disease activity (P < 0.005), and total BDCAF score (P = 0.008 and P < 0.000, respectively). In conclusion, the presence of a newly-developed erythema nodosum, superficial thrombophlebitis, or joint involvement may be associated with higher levels of ESR and CRP. Also, correlations between these indices and general disease activity scores may contribute the overall disease activity perception in BD.
© 2013 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24261602     DOI: 10.1111/ijd.12224

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

1.  Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet's disease.

Authors:  Nuh Ataş; Hakan Babaoğlu; Ertuğrul Demirel; Bülent Çelik; Reyhan Bilici Salman; Hasan Satış; Hazan Karadeniz; Aslıhan Avanoğlu Güler; Seminur Haznedaroğlu; Berna Göker; Abdurrahman Tufan; Mehmet Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2020-07-21

2.  Serum PLR and LMR in Behçet's disease: Can they show the disease activity?

Authors:  Ying Jiang; Mingcui Zang; Shanshan Li
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

3.  Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease.

Authors:  Haruka Miyazaki; Daisuke Watanabe; Norihiro Okamoto; Eri Tokunaga; Yuna Ku; Haruka Takenaka; Namiko Hoshi; Makoto Ooi; Yuzo Kodama
Journal:  BMC Gastroenterol       Date:  2022-03-28       Impact factor: 3.067

Review 4.  Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist.

Authors:  Nishi Shah; Maria S Asdourian; Ted V Jacoby; Steven T Chen
Journal:  Curr Dermatol Rep       Date:  2022-07-16

5.  Multiple aneurysms and gastrointestinal involvement in Behcet's disease: A case report.

Authors:  Mengdi Wang; Weiwei Sun; Zhenjie Chen; Xiaona Wang; Jie Lv; Quanming Tan; Yaoxian Wang; Jingwei Zhou
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.